Drug Shortage Report for OXALIPLATIN

Last updated on 2019-07-02 History
Report ID 85491
Drug Identification Number 02444763
Brand name OXALIPLATIN
Common or Proper name Oxaliplatin
Company Name PFIZER CANADA ULC
Active Ingredient(s) OXALIPLATIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 40mL vial
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-05-29
Estimated end date
Actual end date 2019-06-28
Shortage status Resolved
Updated date 2019-07-02
Company comments Other presentations are available
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-07-02 French Compare
v3 2019-07-02 English Compare
v2 2019-06-04 French Compare
v1 2019-06-04 English Compare